cannabinoid CN2 receptor agonist (Axxam SpA)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namecannabinoid CN2 receptor agonist (Axxam SpA)
Drug Alias Namecannabinoid CB2 receptor agonist (Axxam SpA)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor agonists
TargetsCannabinoid CB2 receptor
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAxxam Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAxxam Spa
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A